PMDA announcement on voluntary checks of package inserts for blood glucose measuring devices
「血糖測定機器等に係る添付文書の自主点検等について」を掲載しました
Published: 2026-01-07 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · First detected by this dashboard: 2026-08-06
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
On 2026-01-07, the Pharmaceuticals and Medical Devices Agency (PMDA) announced that it had posted an item on voluntary checks of package inserts for blood glucose measuring devices and related equipment. The title does not specify the checks or the scope of the related equipment.
Business Impact
Manufacturers of blood glucose measuring devices and related equipment may be affected because the announcement concerns voluntary checks of those products' package inserts.
Recommended Action
Review of the official Japanese posting could clarify the covered devices, intended recipients, and details of the voluntary checks.